• KOL
    • KOLs Community
    • Pyogenic
    • Pyogenic Granuloma
    • Harry P W Kozakewich
    • Harry P W Kozakewich

      Harry P W Kozakewich

      Departments of, Pathology | Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA; | Department of Pathology, Boston Children's Hospital, ...

       

       

      KOL Resume for Harry P W Kozakewich

      Year
      2022

      Departments of, Pathology

      2021

      Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA;

      2020

      Pathology

      Vascular Anomalies Center, Boston Children’s Hospital, Boston, MA

      2019

      Department of Pathology, Vascular Anomalies Center, Boston Children's Hospital, Harvard University, Boston, MA.

      2018

      2Pathology, and.

      Vascular Anomalies Center, Boston Children’s Hospital, Boston, MA, USA

      2017

      Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

      2016

      Vascular Anomalies Center, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA

      2015

      Department of Pathology, Pathology, Boston Children’s Hospital, Boston, MA

      Vascular Anomalies Center, Boston Children's Hospital, Boston, Massachusetts.

      2014

      Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

      Vascular Anomalies Center, Pathology

      Boston Children's Hospital Boston Massachusetts

      2013

      Pathology (H.K.), Boston, Massachusetts 02115

      2012

      Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA

      Harry P.W. Kozakewich and Barbara R. Pober are co-senior authors.

      Vascular Anomalies Center, Children’s Hospital Boston and Harvard Medical School

      2011

      Department of Pathology, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA

      2010

      Department of Pathology, Children's Hospital Boston, Boston, MA, USA

      2009

      Vascular Anomalies Center, Children's Hospital Boston, Boston, Mass

      Department of Pathology, Childrens Hospital Boston, Harvard Medical School, 02115, Boston, MA, USA

      Plastic Surgery, Baylor College of Medicine, Houston, Texas

      2008

      Department of Pathology, Children’s Hospital Boston and Harvard Medical School, 300 Longwood Ave, 02115, Boston, MA, USA

      2007

      Department of Pathology, Vascular Anomalies Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts

      Vascular Anomalies Center, Children's Hospital Boston, Harvard Medical School, Boston MA, USA

      2006

      Department of Pathology and

      2005

      From the Departments of Urology and Pathology (HPK), Children’s Hospital Boston, Boston, Massachusetts

      Vascular Anomalies Center, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA

      Associate Professor, Department of Pathology, Harvard Medical School, Children’s Hospital, Boston, MA.

      2004

      From the *Department of Pathology, †Orthopedics, and ‡Radiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA; and §Genzyme Genetics, Santa Fe, NM.

      Department ofPathology, Children's Hospital Boston, Boston, Massachusetts, USA

      2003

      Boston, Mass. From the Division of Plastic Surgery, Craniofacial Center, and the Department of Pathology, Children’s Hospital, Harvard Medical School.

      2002

      Department of Pathology (H.P.W.K.), Boston, Massachusetts 02115

      Boston, Mass.

      2001

      Department of Pathology, Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA, US

      Paris, France, Brussels, Belgium, and Boston, Mass.

      2000

      From the Division of Endocrinology (S.A.H., M.V., A.J.B.), the Departments of Pathology and Pediatrics (H.P.W.K.), and the Department of Surgery and the Vascular Anomalies Center (S.J.F.), Children's Hospital

      1998

      Division of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital, Harvard Medical School, Boston, Massachusetts

      Department of Surgery, Children's Hospital, Boston, MA USA.

      1997

      Division of Women's and Perinatal Pathology, Department of Pathology, and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital Boston, MA, USA

      From the Departments of Surgery and Pathology, Children's Hospital and Harvard Medical School, Boston, Massachusetts.

       

       

      Harry P W Kozakewich: Influence Statistics

      Sample of concepts for which Harry P W Kozakewich is among the top experts in the world.
      Concept World rank
      clinically malignant tumors #1
      challenging pediatric #1
      mesenteric lipoblastoma #1
      vascular malformations sclerotherapy #1
      fabp5 cell types #1
      genes pyogenic granuloma #1
      vascular immunostains prox1 #1
      intraspinal involvement #1
      diagnosed intralobar #1
      specific pten mutations #1
      histopathology vascular anomalies #1
      splenic epidermoid cysts #1
      lobar emphysema ccam #1
      fabps inflammatory activity #1
      vascular anomalies histopathology #1
      malformation lobar #1
      vessels peribronchial #1
      parenchymal maldevelopment ccam #1
      atresia ils #1
      thrombocytopenia cutaneous involvement #1
      clinically benign neoplasms #1
      macrophages samples #1
      ccell hyperplasia 55 #1
      bpd fabp5 #1
      documented survivors disease #1
      vascular growth flt4 #1
      engineered embolus #1
      vessels bronchopulmonary #1
      somatic activating variants #1
      bpd fabp4 concentrations #1
      n11 ccam #1
      recurrence fava #1
      questions familial component #1
      prenatally diagnosed lesions #1
      vascular immunostains #1
      ccam n11 #1
      vascular sclerotherapy #1
      angiomatosis thrombocytopenia #1
      cutaneovisceral #1
      publication female granuloma #1
      thyroid findings brrs #1
      rhabdomyosarcoma stromal #1
      congenital megacalyces #1
      glut1 excellent marker #1
      proteins peribronchial #1
      pain joint contractures #1
      immense daily practice #1
      macrophages fabp5 concentrations #1
      prox1 lymphatics #1

       

      Prominent publications by Harry P W Kozakewich

      KOL-Index: 19344

      Intracranial myxoid mesenchymal tumor harboring EWSR1 fusions with CREB family of genes was recently described, and it resembles the myxoid variant of angiomatoid fibrous histiocytoma. We present three pediatric patients with intracranial EWSR1-rearranged myxoid mesenchymal neoplasm and provide a molecular genetic characterization of these tumors. Clinical histories and imaging results were reviewed. Histology, immunohistochemistry, EWSR1, FUS, NR4A3 fluorescence in situ hybridization ...

      Known for Myxoid Variant | Angiomatoid Fibrous Histiocytoma | Mesenchymal Tumors | Gene Fusion | Fish Ngs
      KOL-Index: 17270

      Fewer than 15% of gastrointestinal stromal tumors (GIST) in pediatric patients harbor KIT or platelet-derived growth factor receptor alpha (PDGFRA) mutations in contrast to a mutation rate of 80% in adult GISTs. However, some therapeutic inhibitors of KIT have efficacy in pediatric GIST, suggesting that KIT may, nevertheless, play an important role in oncogenesis. In adult GIST, characteristic cytogenetic changes occur during progression to malignancy. A better understanding of ...

      Known for Stromal Tumors | Kit Pdgfra | Pediatric Gists | Growth Factor | Type Gastrointestinal
      KOL-Index: 14450

      Morphological, cytogenetic, and biological evidence supports a relationship between congenital (infantile) fibrosarcoma (CFS) and congenital mesoblastic nephroma (CMN). These tumors have a very similar histological appearance, and they are both associated with polysomies for chromosomes 8, 11, 17, and 20. Recently, CFS was shown to contain a novel t(12; 15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. The aims of this study were to determine whether congenital mesoblastic ...

      Known for Congenital Mesoblastic Nephroma | Ntrk3 Gene | Situ Hybridization | Trkc Receptors | Fusion Etv6
      KOL-Index: 12950

      BACKGROUND: Pulmonary arteriovenous malformations (PAVMs) are a known complication after some types of cavopulmonary anastomoses (CVPAs). Their cause is unknown, but they may be related to the absence of pulsatile flow or the presence or absence of circulating factors. These PAVMs are diffuse and are presumed to be progressive and irreversible.

      METHODS AND RESULTS: All patients with congenital heart disease (CHD) seen at Children's Hospital, Boston, Mass, between 1970 and 1993 were ...

      Known for Congenital Heart Disease | Hepatic Venous | Patients Chd | Biliary Atresia | Pulmonary Veins
      KOL-Index: 12725

      OBJECTIVES: To test the hypothesis that somatic phosphatidylinositol-4,5-bisphospate 3-kinase, catalytic subunit alpha (PIK3CA) mutations would be found in patients with more common disorders including isolated lymphatic malformation (LM) and Klippel-Trenaunay syndrome (KTS).

      STUDY DESIGN: We used next generation sequencing, droplet digital polymerase chain reaction, and single molecule molecular inversion probes to search for somatic PIK3CA mutations in affected tissue from patients ...

      Known for Somatic Mutations | Patients Lm | Overgrowth Disorders | Boston Childrens Hospital | 3 Kinases
      KOL-Index: 12056

      Metachondromatosis (MC) is a rare, autosomal dominant, incompletely penetrant combined exostosis and enchondromatosis tumor syndrome. MC is clinically distinct from other multiple exostosis or multiple enchondromatosis syndromes and is unlinked to EXT1 and EXT2, the genes responsible for autosomal dominant multiple osteochondromas (MO). To identify a gene for MC, we performed linkage analysis with high-density SNP arrays in a single family, used a targeted array to capture exons and ...

      Known for Maffucci Syndrome | Ptpn11 Mutations | Ollier Disease | Metachondromatosis Mc | Multiple Enchondromatosis
      KOL-Index: 11223

      Kaposiform hemangioendothelioma is a distinctive vascular neoplasm affecting predominantly children and neonates. In neonates it needs to be differentiated from common infantile hemangioma and other vascular lesions of infancy. Kaposiform hemangioendothelioma immunoreacts with vascular endothelial growth factor receptor 3, and partial lymphothelial differentiation of this lesion has been suggested. D2-40 has been recently proposed as a selective marker of lymphatic endothelium. We ...

      Known for Kaposiform Hemangioendothelioma | Monoclonal Antibodies | Immunohistochemical Analysis | Vascular Lesions | Murinederived Antigens
      KOL-Index: 10931

      Vascular lesions of bone are rare and their terminology is not standardized. Herein, we report 77 patients with such lesions in order to characterize their morphologic spectrum and the applicability of the International Society for the Study of Vascular Anomalies (ISSVA) classification. In this system, malformations are structural anomalies distinguishable from tumors, which are proliferative. The radiologic images/reports and pathologic materials from all patients were reviewed. All ...

      Known for Vascular Lesions | Issva Classification | Soft Tissue | Bone Tumors | International Society
      KOL-Index: 10929

      BACKGROUND: Phosphatase and tensin homolog deleted on chromosome ten (PTEN)-hamartoma tumor syndrome (PHTS) is a complex disorder caused by germline inactivating mutations of the PTEN tumor suppressor gene. PHTS includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), and Proteus-like syndromes. Affected individuals develop both benign and malignant tumors in a variety of tissues, including the thyroid. This study is to better characterize and describe the thyroid ...

      Known for Thyroid Pathology | Tumor Syndrome | Papillary Carcinoma | Pten Mutations | Ccell Hyperplasia
      KOL-Index: 10795

      Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte- and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and ...

      Known for Endothelial Cell | Binding Protein | Vegf Fabp4 | Fatty Acid | Proliferation Ecs
      KOL-Index: 10673

      Infantile fibrosarcoma and congenital mesoblastic nephroma are tumors of infancy traditionally associated with the ETV6–NTRK3 gene fusion. However, a number of case reports have identified variant fusions in these tumors. In order to assess the frequency of variant NTRK3 fusions, and in particular whether the recently identified EML4–NTRK3 fusion is recurrent, 63 archival cases of infantile fibrosarcoma, congenital mesoblastic nephroma, mammary analog secretory carcinoma and secretory ...

      Known for Ntrk3 Fusion | Infantile Fibrosarcoma | Mesoblastic Nephroma | Situ Hybridization | Rna Sequencing
      KOL-Index: 10292

      BACKGROUND: Malignant soft-tissue tumors often present substantial diagnostic challenges. Chromosome aberrations that might be diagnostic have been identified in some types of soft-tissue tumors, but the overall frequency and diagnostic relevance of these aberrations have not been established.

      METHODS: We attempted to determine the karyotypes of a series of 62 consecutive, unselected malignant spindle-cell or small round-cell soft-tissue tumors (from 46 adults and 16 children) after ...

      Known for Tissue Tumors | Diagnostic Relevance | Clonal Cytogenetic Aberrations | Malignant Soft | Child Child
      KOL-Index: 10243

      CONTEXT: Thyroid cancer is the most common endocrine malignancy, but due to its rare occurrence in the pediatric population, the cancer risk of childhood thyroid nodules is incompletely defined, and optimal management of children with suspected nodules is debated.

      OBJECTIVE: The aim was to study the presenting features and cancer risk of sporadic childhood thyroid nodules using a standardized clinical assessment and management plan.

      DESIGN AND SETTING: Boston Children's Hospital and ...

      Known for Thyroid Nodules | Adults Children | Cancer Risk | Neck Ultrasonography | Pediatric Population
      KOL-Index: 10240

      Children with a large vascular tumor and associated Kasabach-Merritt coagulopathy respond inconsistently to therapy and have a high mortality rate. For this reason, we undertook a retrospective study of 21 such patients, and focused on clinical, radiographic, and histopathologic features. The male to female ratio was 1:1.6. Tumor was noted at birth in 50 percent of patients; the remainder appeared throughout infancy. The location was cervicofacial (n = 2), shoulder/upper limb (n = 4), ...

      Known for Merritt Phenomenon | Infantile Hemangioma | Kaposiform Hemangioendothelioma | Thrombocytopenic Coagulopathy | Mortality Rate
      KOL-Index: 9994

      Inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD). Fatty acid-binding proteins (FABPs) 4 and 5 regulate the inflammatory activity of macrophages. Whether FABPs 4 and 5 could play a role in the pathogenesis of BPD via the promotion of macrophage inflammatory activity is unknown. This study sought to examine whether the expression levels of FABP4 and FABP5 were altered in bronchoalveolar lavage fluid and lung tissue in a baboon model of BPD. This study ...

      Known for Fatty Acid | Binding Proteins | Bronchopulmonary Dysplasia Bpd | Fabp4 Fabp5 | Endothelial Cells

      Key People For Pyogenic Granuloma

      Top KOLs in the world
      #1
      Philip H Cooper
      pyogenic granuloma microcystic adnexal carcinoma eosinophilic cellulitis
      #2
      Stacey E Mills
      cell carcinoma situ hybridization differential diagnosis
      #3
      John B Mulliken
      vascular malformations hemifacial microsomia gills score
      #4
      Nooshin Mohtasham
      oral cavity verrucous carcinoma squamous cell
      #5
      Karen Wiss
      pyogenic granuloma incontinentia pigmenti tuberous sclerosis
      #6
      Stephen J Patrice
      pyogenic granuloma lobular capillary hemangioma multiinstitutional experience

      Harry P W Kozakewich:Expert Impact

      Concepts for whichHarry P W Kozakewichhas direct influence:Pyogenic granuloma,  Bronchial atresia,  Kaposiform hemangioendothelioma,  Kaposiform lymphangiomatosis,  Vascular malformations,  Congenital hemangioma,  Hepatic hemangiomas,  Vascular anomalies.

      Harry P W Kozakewich:KOL impact

      Concepts related to the work of other authors for whichfor which Harry P W Kozakewich has influence:Vascular anomalies,  Infantile hemangioma,  Situ hybridization,  Kaposiform hemangioendothelioma,  Endothelial cells,  Soft tissue,  Thyroid nodules.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Departments of, Pathology | Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA; | Department of Pathology, Boston Children's Hospital, Boston, MA | Department of Pathology, Boston Children’s Hospital, Boston, M

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.